Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancerCarmen Behrens, Heather Y Lin, J Jack Lee, et al.
Medical Sciences (Basel, Switzerland)|May 27, 2026
Loss of PTEN as an Independent Poor Prognosis Indicator in Lung Adenocarcinoma, but Not in Squamous Cell Carcinoma, Is Associated with an Immunosuppressive Tumor Microenvironment and Distinct Co-Mutational ProfilesMaeva Houry, Shannon J Silva, Maider Artola, et al.
Cancer Medicine|April 20, 2018
Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapyApar Pataer, Ruping Shao, Arlene M Correa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesionsCarmen Behrens, Lei Feng, Humam Kadara, et al.
Cancer|November 2, 2006
Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesionsXiming Tang, Diane Liu, Shishir Shishodia, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 26, 2009
EphA2 in the early pathogenesis and progression of non-small cell lung cancerJennifer M Brannan, Banibrata Sen, Babita Saigal, et al.
Cancer Medicine|August 29, 2019
Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancerBin Shi, Carmen Behrens, Viralkumar Vaghani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2010
Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patientsAbujiang Pataer, Maria Gabriela Raso, Arlene M Correa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 10, 2009
Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lungLudmila Prudkin, Diane D Liu, Natalie C Ozburn, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 3, 2017
Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung CancerBoris Sepesi, Edwin Parra Cuentas, Jaime Rodriguez Canales, et al.
Pageof 17